Contact
Please use this form to send email to PR contact of this press release:
Argent BioPharma (ASX:RGT) Unlocks Huge Potential as Epilepsy Treatment CannEpil® Gains Traction in Key Markets
TO:
Roby Zomer
Argent Biopharma